Envestnet Portfolio Solutions’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Buy
105,500
+23,240
+28% +$2.72M 0.07% 181
2026
Q1
$9.9M Sell
82,260
-10,477
-11% -$1.21M 0.05% 188
2025
Q4
$9.76M Buy
92,737
+12,461
+16% +$1.17M 0.03% 242
2025
Q3
$6.74M Sell
80,276
-7,690
-9% -$633K 0.02% 293
2025
Q2
$6.96M Sell
87,966
-41,188
-32% -$3.27M 0.03% 283
2025
Q1
$11.6M Sell
129,154
-22,349
-15% -$2.09M 0.04% 206
2024
Q4
$15.1M Sell
151,503
-33,679
-18% -$3.47M 0.05% 183
2024
Q3
$21M Buy
185,182
+362
+0.2% +$43K 0.07% 138
2024
Q2
$22.9M Sell
184,820
-21,501
-10% -$2.77M 0.08% 125
2024
Q1
$27.2M Buy
206,321
+42,178
+26% +$5.2M 0.1% 104
2023
Q4
$17.9M Buy
164,143
+145
+0.1% +$15.1K 0.07% 130
2023
Q3
$16.9M Buy
+163,998
New +$17.7M 0.08% 121

Other funds holding MRK

Envestnet Portfolio Solutions's MRK Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Merck (MRK) stake by 28% in Q2 2026, buying an estimated $2.72M and bringing the position to 105,500 shares worth $13.6M. The position accounts for 0.07% of the portfolio, ranked #181.

Envestnet Portfolio Solutions first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $27.2M in Q1 2024. 1,038 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Envestnet Portfolio Solutions held 105,500 shares of Merck worth $13.6M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 23,240 Merck shares in Q2 2026, an estimated $2.72M.
  • Merck made up 0.07% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #181 holding.
  • Envestnet Portfolio Solutions first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Merck position peaked at $27.2M in Q1 2024.
  • 1,038 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.